新光药业
(300519)
| 流通市值：16.40亿 | | | 总市值：22.99亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 424,612,128.76 | 470,553,459.72 | 595,843,819.92 | 543,945,792.9 |
| 应收票据及应收账款 | 17,009,136.33 | 10,117,686.1 | 7,753,496.42 | 9,988,937.91 |
| 应收账款 | 17,009,136.33 | 10,117,686.1 | 7,753,496.42 | 9,988,937.91 |
| 应收款项融资 | 707,601.2 | 721,734.75 | 1,046,966.56 | 748,356.48 |
| 预付款项 | 3,618,655.86 | 2,515,796.54 | 3,585,065.88 | 2,426,448.68 |
| 其他应收款合计 | 66,822.64 | 100,367.88 | 130,277.23 | 180,188.25 |
| 存货 | 61,700,552.13 | 63,694,762.26 | 50,335,058.98 | 71,418,704.23 |
| 其他流动资产 | 946,226.07 | 1,339,506.72 | 1,158,132.76 | 1,459,871.55 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 753,661,122.99 | 739,043,313.97 | 799,852,817.75 | 785,168,300 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 21,415,168.1 | 21,123,394.03 | 20,916,513.31 | 21,395,621.76 |
| 固定资产 | 109,011,905.77 | 112,614,156.97 | 115,492,535.75 | 104,472,731.6 |
| 在建工程 | 121,332.74 | 43,601.77 | 103,365.11 | 10,999,084.05 |
| 无形资产 | 7,948,803.43 | 8,020,757.22 | 8,093,764.01 | 8,166,770.8 |
| 递延所得税资产 | 293,371.73 | 197,850.54 | 258,597.9 | 203,282.15 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 138,790,581.77 | 141,999,760.53 | 144,864,776.08 | 145,237,490.36 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 892,451,704.76 | 881,043,074.5 | 944,717,593.83 | 930,405,790.36 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 55,286,366.71 | 62,739,855.6 | 60,815,965.99 | 63,875,802.19 |
| 应付账款 | 55,286,366.71 | 62,739,855.6 | 60,815,965.99 | 63,875,802.19 |
| 合同负债 | 363,748.68 | 666,711.19 | 2,724,809.9 | 157,191.87 |
| 应付职工薪酬 | 729,766.68 | 660,142.36 | 595,332.09 | 4,026,317.31 |
| 应交税费 | 7,935,946.99 | 1,556,914.36 | 3,990,264.54 | 4,765,567.07 |
| 其他应付款合计 | 1,178,226.84 | 1,383,628.03 | 814,662.85 | 4,234,883.79 |
| 其他流动负债 | 47,287.33 | 86,672.45 | 354,225.29 | 20,434.94 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 65,541,343.23 | 67,093,923.99 | 69,295,260.66 | 77,080,197.17 |
| 非流动负债: | | | | |
| 长期应付款 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 |
| 递延收益 | 6,628,232.74 | 6,189,720.14 | 6,516,079.34 | 6,842,438.54 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 8,990,619.2 | 8,552,106.6 | 8,878,465.8 | 9,204,825 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 74,531,962.43 | 75,646,030.59 | 78,173,726.46 | 86,285,022.17 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,000,000 | 160,000,000 | 160,000,000 | 160,000,000 |
| 资本公积 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 |
| 其他综合收益 | 3,301,635.95 | 3,053,627.99 | 2,877,779.38 | 3,285,021.56 |
| 盈余公积 | 111,923,292.31 | 111,923,292.31 | 111,923,292.31 | 111,923,292.31 |
| 未分配利润 | 381,405,779.55 | 369,131,089.09 | 430,453,761.16 | 407,623,419.8 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 817,919,742.33 | 805,397,043.91 | 866,543,867.37 | 844,120,768.19 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 817,919,742.33 | 805,397,043.91 | 866,543,867.37 | 844,120,768.19 |
| 负债和股东权益合计 | 892,451,704.76 | 881,043,074.5 | 944,717,593.83 | 930,405,790.36 |
| 公告日期 | 2024-10-24 | 2024-08-27 | 2024-04-26 | 2024-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |